PP
IART icon

PDT Partners’s Integra LifeSciences IART Stock Holding History

PDT Partners’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-10,770
Closed -$456K – 755
2022
Q3 		$456K Buy
10,770
+6,959
+183% +$357K 0.07% 458
2022
Q2 		$206K Buy
+3,811
New +$229K 0.02% 825

Other funds holding IART

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
CB
Cooke & Bieler Philadelphia, Pennsylvania $8.84B AUM 6.92% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

PDT Partners's IART Position: Q4 2022 in Review

PDT Partners sold out of Integra LifeSciences (IART) in Q4 2022, closing a stake of 10,770 shares — an estimated $456K sold.

PDT Partners first reported a position in IART in Q2 2022 and held it in 2 quarters. The position peaked at $456K in Q3 2022. 281 funds tracked by Wall St. Rank hold IART as of Q4 2022.

  • PDT Partners reported no remaining Integra LifeSciences position as of Q4 2022 after selling out during the quarter.
  • PDT Partners sold 10,770 Integra LifeSciences shares in Q4 2022, an estimated $456K.
  • PDT Partners first reported a position in Integra LifeSciences in Q2 2022 and held it in 2 quarters.
  • PDT Partners's Integra LifeSciences position peaked at $456K in Q3 2022.
  • 281 funds tracked by Wall St. Rank held Integra LifeSciences as of Q4 2022.

Based on PDT Partners's 13F filing for Q4 2022, filed 14 Feb 2023.